Skip to main content
UHS
NYSE Industrial Applications And Services

UHS 10-Q: Q3 EPS $5.22, Net Income Down 17% on $37M Liability Reserve Increase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$195.5
Mkt Cap
$11.52B
52W Low
$140.08
52W High
$246.325
52W Position info
40% above low
Off High info
21% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

UHS sits 40% above its 52-week low of $140.08.

Summary

UHS's full Q3 10-Q shows revenue up 5.3% to $4.73 billion but net income down 17% to $309 million, with a $37 million liability reserve increase (including $26 million tied to the Cumberland settlement) and a projected ~$500 million annual Medicaid funding hit by 2032.


Key Events · Earnings and Guidance · UHS

  • Q3 Earnings: Revenue Up, Profit Down 17%

    Net revenues rose 5.3% to $4.733 billion, but net income attributable to UHS fell 17% to $308.7 million ($5.22 diluted EPS) from $373.0 million ($5.86) a year earlier.

  • $37M Liability Reserve Increase Hits Results

    Pre-tax income before noncontrolling interests fell 17% to $413.9 million, including a $37 million increase to self-insured professional and general liability reserves, $26 million of it tied to the August 2026 Cumberland Litigation tentative settlement.

  • Medicaid Funding Cut of ~$500M by 2032

    UHS estimates the One Big Beautiful Bill Act will reduce its aggregate annual net benefit from state Medicaid supplemental programs — about $1.584 billion projected for 2026 — by roughly $500 million by 2032, phased in from 2028.

  • Facility License and Certification Losses

    Laurel Ridge lost Medicare/Medicaid certification effective April 30, 2026 and posted a $16 million pre-tax loss in the first nine months versus $23 million of income in 2025; Provo Canyon's Utah licenses were revoked in July 2026 and adolescent licenses were voluntarily relinquished.


Analysis · UHS · Industrial Applications And Services

The headline Q3 numbers were already public on October 27, but the full 10-Q fills in what drove the 17% drop in pre-tax income: a $37 million increase to self-insured professional and general liability reserves, $26 million of which stems from the August 2026 tentative settlement of the Cumberland Litigation. It also quantifies the regulatory drag ahead — the company estimates the One Big Beautiful Bill Act will cut its ~$1.584 billion annual Medicaid supplemental-program net benefit by roughly $500 million by 2032 — and details the loss of Medicare/Medicaid certification at Laurel Ridge ($16 million pre-tax loss in the first nine months versus $23 million of income in 2025) and the revocation of Provo Canyon's Utah licenses. Against that, revenue grew 5.3% to $4.73 billion and nine-month operating cash flow rose to $1.481 billion from $1.290 billion, funding $1.003 billion of acquisitions (Talkspace at $820 million, Ireland facilities at $178 million) and $730 million of buybacks.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, UHS was trading at $195.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.5B. The 52-week trading range was $140.08 to $246.33. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UHS - Latest Insights

UHS
Oct 27, 2026, 4:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $177.32
Real-time Price: $179.43 info
Change: +$2.11 (+1%) info
Market Cap: $10.342B info
UHS
Aug 17, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $170.53
Real-time Price: $179.43 info
Change: +$8.90 (+5%) info
Market Cap: $10.342B info
UHS
Aug 13, 2026, 9:23 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $172.45
Real-time Price: $179.43 info
Change: +$6.98 (+4%) info
Market Cap: $10.342B info
UHS
Aug 13, 2026, 9:21 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $171.21
Real-time Price: $179.43 info
Change: +$8.22 (+5%) info
Market Cap: $10.342B info
UHS
Aug 11, 2026, 7:54 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $169.00
Real-time Price: $179.43 info
Change: +$10.43 (+6%) info
Market Cap: $10.342B info